SUPERNUS PHARMACEUTICALS, INC. — Regulatory Filings 2015

Aug 28, 2015

8-K 1 a15-18646_18k.htm 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 27, 2015

Supernus Pharmaceuticals, Inc.

(Exact name of registrant as specified in its charter)

Delaware

(State or other jurisdiction of Incorporation)

001-35518	20-2590184
(Commission File Number)	(IRS Employer Identification No.)

1550 East Gude Drive, Rockville MD	20850
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: (301) 838-2500

Not Applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

SEQ.=1,FOLIO='',FILE='C:\JMS\109184\15-18646-1\task7566664\18646-1-ba.htm',USER='109184',CD='Aug 27 23:41 2015'

Item 8.01 Other Events.

On August 27, 2015, Supernus Pharmaceuticals, Inc. issued a press release announcing that the Company’s management will be hosting investor meetings during the FBR Healthcare Conference on September 9, 2015. A copy of this press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibit

The following document is furnished as an Exhibit pursuant to Item 8.01 hereof:

Exhibit 99.1 — Press Release Dated August 27, 2015.

2

SEQ.=1,FOLIO='2',FILE='C:\JMS\109184\15-18646-1\task7566664\18646-1-ba.htm',USER='109184',CD='Aug 27 23:41 2015'

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Gregory S. Patrick
Gregory S. Patrick
Vice-President and Chief Financial Officer

3

SEQ.=1,FOLIO='3',FILE='C:\JMS\109184\15-18646-1\task7566664\18646-1-ba.htm',USER='109184',CD='Aug 27 23:41 2015'

EXHIBIT INDEX

Number — 99.1	Press Release Dated August 27, 2015.	Attached

4

SEQ.=1,FOLIO='4',FILE='C:\JMS\109184\15-18646-1\task7566664\18646-1-ba.htm',USER='109184',CD='Aug 27 23:41 2015'